老虎證券
Invest
Pricing
Rewards
Support
About
Quotes
TigerAI
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
SL Science Holding Ltd
1.81
-0.1000
-5.24%
盤後：
1.81
0.0000
0.00%
16:10 EDT
成交量：
12.93萬
成交額：
24.21萬
市值：
10.14億
市盈率：
-2.81
高：
1.93
開：
1.91
低：
1.74
收：
1.91
52周最高：
14.50
52周最低：
1.74
股本：
5.60億
流通股本：
2.27億
量比：
0.86
換手率：
0.06%
股息：
- -
股息率：
- -
每股收益(TTM):
-0.6447
每股收益(LYR):
-0.4532
淨資產收益率：
-25.62%
總資產收益率：
-14.70%
市淨率：
214.27
市盈率(LYR):
-3.99
資料載入中...
總覽
公司
新聞資訊
公告
公司資料
公司名字：
SL Science Holding Ltd
交易所：
NASDAQ
成立時間：
- -
員工人數：
15
公司地址：
No. 479, Chongyang Rd.,11th Floor, Nangang Dist.,Taipei,Taiwan
官網：
http://www.slbtgroup.com
郵編：
115010
電話：
886 2 2651 6826
傳真：
- -
簡介：
SL Science Holding Limited於2025年3月18日在開曼群島註冊成立，為一家豁免的股份有限公司。該公司通過其子公司開展業務，專註於開發細胞和基因療法，包括Armed-T和Gamma Delta T細胞技術以及外泌體應用。其商業模式以與生物製藥公司合作為核心。公司處於臨床前開發階段，尚未獲得FDA對任何候選產品的批准。
董事
名稱
職位
William Wang Ching Dong
Chief Executive Officer, Director and Chairman of Board
Ethan Shen
Chief Technology Officer and Director
John C. General
Independent Director
Joseph Levinson
Independent Director
Kwo Liang Chen
Independent Director
Mingche Liu
Independent Director
Qian Xu
Independent Director
股東
名稱
職位
William Wang Ching Dong
Chief Executive Officer, Director and Chairman of Board
Ray Leung
Chief Financial Officer
Ethan Shen
Chief Technology Officer and Director
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"老虎國際,美股交易,港股交易,交易美股,股票信息,股價,美股行情,美股打新,港股打新,IPO打新,購買美股,全球投資","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/hant/stock/SLBT/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SLBT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLBT\",,,,,undefined,":{"symbol":"SLBT","market":"US","secType":"STK","nameCN":"SL Science Holding Ltd","latestPrice":1.81,"timestamp":1789588800000,"preClose":1.91,"halted":0,"volume":129310,"hourTrading":{"tag":"盘后","latestPrice":1.81,"preClose":1.81,"latestTime":"16:10 EDT","volume":9,"amount":16.7238009,"timestamp":1789589404494,"change":0,"changeRate":0,"amplitude":0.07989},"delay":0,"changeRate":-0.05235602094240831,"floatShares":226857620,"shares":560000000,"eps":-0.644729,"marketStatus":"盤後交易","change":-0.1,"latestTime":"09-16 18:12:16 EDT","open":1.91,"high":1.93,"low":1.74,"amount":242142,"amplitude":0.099476,"askPrice":2.14,"askSize":100,"bidPrice":1.74,"bidSize":150,"shortable":0,"etf":0,"ttmEps":-0.644729,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1789603200000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":1.91,"preHourTrading":{"tag":"盘前","latestPrice":1.97,"preClose":1.91,"latestTime":"09:02 EDT","volume":136,"amount":260.6700032,"timestamp":1789563721833,"change":0.06,"changeRate":0.031414,"amplitude":0.04712},"postHourTrading":{"tag":"盘后","latestPrice":1.81,"preClose":1.81,"latestTime":"16:10 EDT","volume":9,"amount":16.7238009,"timestamp":1789589404494,"change":0,"changeRate":0,"amplitude":0.07989},"volumeRatio":0.857897},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SLBT\",,,,,undefined,":{"symbol":"SLBT","floatShares":226857620,"roa":"-14.70%","roe":"-25.62%","lyrEps":-0.453239,"volumeRatio":0.857897,"shares":560000000,"dividePrice":0,"high":1.93,"amplitude":0.099476,"preClose":1.91,"low":1.74,"week52Low":1.74,"pbRate":"214.27","psRate":"309.96","week52High":14.5,"institutionHeld":0,"latestPrice":1.81,"committee":0.2,"eps":-0.644729,"divideRate":0,"volume":129310,"delay":0,"ttmEps":-0.644729,"open":1.91,"prevYearClose":10.545,"prevWeekClose":2.06,"prevMonthClose":2.73,"prevQuarterClose":4.79,"fiveDayClose":2.61,"twentyDayClose":2.72,"sixtyDayClose":4.52},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SLBT\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SLBT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SLBT\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SLBT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SLBT","date":"2026-09-15","current":-2.807381,"percent":0.558824,"low":-791.521742,"twenty":-648.521742,"median":-621.739133,"eighty":-363.724186,"high":-182.131353,"avg":-505.756698,"sd":178.38716,"marketCap":1172844094},"quantilePoints":[{"date":"2026-07-31","current":-364.945192,"twenty":-373.627903,"median":-369.015213,"eighty":-360.061167,"marketCap":434771250},{"date":"2026-08-07","current":-370.371886,"twenty":-395.063345,"median":-373.085233,"eighty":-362.50318,"marketCap":441236250},{"date":"2026-08-14","current":-184.859913,"twenty":-376.612585,"median":-361.892676,"eighty":-183.768489,"marketCap":438003750},{"date":"2026-08-21","current":-648.043481,"twenty":-637.043481,"median":-373.085233,"eighty":-189.77132,"marketCap":1535462558},{"date":"2026-08-28","current":-631.30435,"twenty":-637.043481,"median":-398.862031,"eighty":-288.859314,"marketCap":1495801164},{"date":"2026-09-04","current":-753.260872,"twenty":-649.000003,"median":-621.739133,"eighty":-356.398148,"marketCap":1784762752},{"date":"2026-09-11","current":-502.173915,"twenty":-649.478263,"median":-624.130437,"eighty":-361.282173,"marketCap":1189841835},{"date":"2026-09-15","current":-495.000002,"twenty":-648.521742,"median":-621.739133,"eighty":-363.724186,"marketCap":1172844094}],"updateTime":1789596736204},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":1943198251,"employeeNum":15,"address":"No. 479, Chongyang Rd.,11th Floor, Nangang Dist.,Taipei,Taiwan","zipCode":"115010","officePhone":"886 2 2651 6826","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.slbtgroup.com","stockEarnings":[{"period":"1week","weight":-0.271},{"period":"1month","weight":-0.282},{"period":"3month","weight":-0.7006},{"period":"6month","weight":-0.7627},{"period":"1year","weight":-0.8151},{"period":"ytd","weight":-0.8189}],"compareEarnings":[{"period":"1week","weight":-0.0112},{"period":"1month","weight":-0.0244},{"period":"3month","weight":0.0222},{"period":"6month","weight":0.1479},{"period":"1year","weight":0.146},{"period":"ytd","weight":0.1107}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"SL Science Holding Limited於2025年3月18日在開曼群島註冊成立，為一家豁免的股份有限公司。該公司通過其子公司開展業務，專註於開發細胞和基因療法，包括Armed-T和Gamma Delta T細胞技術以及外泌體應用。其商業模式以與生物製藥公司合作為核心。公司處於臨床前開發階段，尚未獲得FDA對任何候選產品的批准。","exchange":"NASDAQ","name":"SL Science Holding Ltd","nameEN":"SL Science Holding Ltd"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"SLBT\",market:\"US\",,,undefined,":{"directors":[{"name":"William Wang Ching Dong","position":"Chief Executive Officer, Director and Chairman of Board"},{"name":"Ethan Shen","position":"Chief Technology Officer and Director"},{"name":"John C. General","position":"Independent Director"},{"name":"Joseph Levinson","position":"Independent Director"},{"name":"Kwo Liang Chen","position":"Independent Director"},{"name":"Mingche Liu","position":"Independent Director"},{"name":"Qian Xu","position":"Independent Director"}],"executives":[{"name":"William Wang Ching Dong","position":"Chief Executive Officer, Director and Chairman of Board"},{"name":"Ray Leung","position":"Chief Financial Officer"},{"name":"Ethan Shen","position":"Chief Technology Officer and Director"}]}}}